Henry Schein Provides Update on CEO Search Process
MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein, Inc. (Nasdaq: HSIC) (the “Company”), the world’s largest provider of health care solutions to office-based dental…
Novo Nordisk’s weight loss pill approved by FDA
The clearance kicks off the next phase of an escalating battle for control of the obesity drug market.
AI and Automation in Healthcare – 2026 Health IT Predictions
As we wrap up another year and get ready for 2026 to begin, it is once again time for everyone’s…
Converting the Skeptics: How VBC Moves Forward From Here
The following is a guest article by Dana McCalley, VP of Value-Based Care at Navina The value-based care (VBC) market…
ANDHealth Secures Funding | Lin Health Raises $11 Million Series A | Automate.clinic’s Latest Funding Round
Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the…
Trump administration nixes Biden-era health IT policies, including AI ‘model cards’
Two proposed rules released Monday would pare back government guardrails around health information technology software, including some put forward by…
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx
EL MONTE, Calif.–(BUSINESS WIRE)–Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”), a technology-based company with a well-established laboratory services business and a…
RevBio® Receives Approval from FDA to Start a Dental Clinical Trial for its Regenerative Bone Glue
LOWELL, Mass.–(BUSINESS WIRE)– #Biomimetic–RevBio, Inc., announced that it has received approval from the U.S. Food and Drug Administration to start…
2025 Year in Review – Healthcare IT Today Podcast Episode 182
With the 182nd episode of the Healthcare IT Today Podcast being one of the last episodse we do this year,…
Why AI Struggles in RCM and How Front-End Data Can Fix It
When a claim fails because of a missing field or outdated insurance detail, it is easy to blame the billing…